💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Brexit, virus worries weigh on European shares; Sanofi down on vaccine delay

Published 12/11/2020, 03:23 AM
Updated 12/11/2020, 04:45 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt
SNY
-
GSK
-
STOXX
-

By Susan Mathew and Amal S

(Reuters) - European shares slipped on Friday, setting up to end an action-packed week on a somber note on worries over the economic impact of a resurgent COVID-19 pandemic and the fate of a Brexit trade deal as well as stalled U.S. stimulus measures.

The pan-European STOXX 600 index slid 0.8%, extending losses after a dour 2021 economic forecast from the European Central Bank had seen it end in the red on Thursday.

The index is set to break a five-week winning streak as a stalemate in talks between the European Union and Britain raised the chances of Britain's exit from the economic bloc without a trade deal.

Investors will be watching for Brexit updates with a Sunday deadline for a last ditch attempt at a deal.

"It's the fears that the talk from both sides has definitely switched to a more negative tone," said David Madden, market analyst at CMC Markets UK, adding markets still hope for some sort of a deal because stocks "aren't falling through the floor."

Drugmaker Sanofi (NASDAQ:SNY)'s 3.1% slide weighed the most, after it said its COVID-19 vaccine candidate developed with GlaxoSmithKline (NYSE:GSK) showed an insufficient immune response in clinical trials. GSK shares were trading flat.

As European bond yields dipped, banks continued their slide. Spain's lender-heavy main index fell 1.9%.

Meanwhile, European Union leaders unblocked a 1.8 trillion euro ($2.18 trillion) financial package late on Thursday to help the economy recover from the pandemic-induced recession.

But in the United States, fiscal stimulus appeared unlikely after Democrat House Speaker Nancy Pelosi suggested that wrangling over a spending package could drag on through Christmas.

A raft of stimulus measures since the onset of the pandemic has lifted sentiment on hopes of a global economic recovery. The STOXX 600 has risen 45% since lows hit in March, but it remains more than 6% down for the year.

Among other individual stocks, Rolls-Royce (OTC:RYCEY) slumped 5.3% after the engineering company downgraded this year's cash outflow forecast and warned the outlook remained challenging.

Telecom gear maker Ericsson (BS:ERICAs) fell to the bottom of the STOXX 600 after filing a U.S. lawsuit against Samsung (KS:005930) for alleged breaches in negotiations for royalty payments and to license patents.

This could impact Ericsson's operating income by 1 billion Swedish crowns ($118.70 million) to 1.5 billion per quarter beginning in the first quarter 2021, the company said.

Europe's telecoms sector dropped 2.3% and was on course for its worst day in over 10 weeks.

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

($1 = 0.8243 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.